TherapeuticsMD Inc (TXMD)
1.87
-0.05
(-2.60%)
USD |
NASDAQ |
Apr 25, 16:00
1.87
0.00 (0.00%)
After-Hours: 20:00
TherapeuticsMD Profit Margin (Quarterly): -175.9% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -175.9% |
| September 30, 2023 | |
| June 30, 2023 | -552.4% |
| March 31, 2023 | -866.1% |
| December 31, 2022 | |
| September 30, 2022 | -8.18K% |
| June 30, 2022 | |
| March 31, 2022 | -7.05K% |
| December 31, 2021 | 65.39% |
| September 30, 2021 | -186.6% |
| June 30, 2021 | -185.4% |
| March 31, 2021 | -198.2% |
| December 31, 2020 | -186.4% |
| September 30, 2020 | -168.6% |
| June 30, 2020 | -485.7% |
| March 31, 2020 | -464.0% |
| December 31, 2019 | -310.9% |
| September 30, 2019 | -134.8% |
| June 30, 2019 | -908.7% |
| March 31, 2019 | -1.00K% |
| December 31, 2018 | -774.0% |
| September 30, 2018 | -1.03K% |
| June 30, 2018 | -882.8% |
| March 31, 2018 | -646.7% |
| December 31, 2017 | -519.5% |
| Date | Value |
|---|---|
| September 30, 2017 | -332.0% |
| June 30, 2017 | -462.9% |
| March 31, 2017 | -530.8% |
| December 31, 2016 | -508.9% |
| September 30, 2016 | -451.9% |
| June 30, 2016 | -479.1% |
| March 31, 2016 | -424.5% |
| December 31, 2015 | -310.5% |
| September 30, 2015 | -375.2% |
| June 30, 2015 | -561.6% |
| March 31, 2015 | -466.9% |
| December 31, 2014 | -382.9% |
| September 30, 2014 | -426.0% |
| June 30, 2014 | -290.5% |
| March 31, 2014 | -324.4% |
| December 31, 2013 | -292.7% |
| September 30, 2013 | -334.4% |
| June 30, 2013 | -288.8% |
| March 31, 2013 | -414.8% |
| December 31, 2012 | -461.6% |
| September 30, 2012 | -410.4% |
| June 30, 2012 | -1.45K% |
| March 31, 2012 | -1.84K% |
| December 31, 2011 | -1.73K% |
| September 30, 2011 | -275.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-8.18K%
Minimum
Sep 2022
65.39%
Maximum
Dec 2021
-1.25K%
Average
-254.6%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -33.01% |
| Return on Assets | -17.27% |
| Return on Invested Capital | -33.01% |
| Operating Margin (Quarterly) | -320.9% |
| Return on Net Operating Assets | -42.52% |